NCT00003357View on ClinicalTrials.gov

Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

November 30, 2001

Study Completion Date

November 30, 2001

Conditions
Breast Cancer
Interventions
BIOLOGICAL

GM2-KLH vaccine

BIOLOGICAL

QS21

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003357 - Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease | Biotech Hunter | Biotech Hunter